Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-08

Clinical Trial Update: Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke [NA]

View source ↗

Summary

A Massachusetts General Hospital-led clinical trial investigating precision clinical and genetic tools for brain health in hemorrhagic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hemorrhagic Stroke | NA | Status: COMPLETED